Racial/Ethnic Disparities in Hypertension Prevalence, Awareness, Treatment, and Control in the United States, 2013 to 2018

Hypertension. 2021 Dec;78(6):1719-1726. doi: 10.1161/HYPERTENSIONAHA.121.17570. Epub 2021 Aug 9.

Authors

Rahul Aggarwal^{1

2}, Nicholas Chiu^{1

2}, Rishi K Wadhera^{1

2}, Andrew E Moran³, Inbar Raber^{1

2}, Changyu Shen², Robert W Yeh², Dhruv S Kazi²

Affiliations

¹ Department of Medicine (R.A., N.C., R.K.W., I.R.), Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
² Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Division of Cardiology (R.A., N.C., R.K.W., I.R., C.S., R.W.Y., D.S.K.), Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
³ Division of General Medicine, Columbia University, New York, NY (A.E.M.).

Abstract

[Figure: see text].

Keywords: United States; adults; blood pressure; health equity; prevalence.

Publication types

Research Support, N.I.H., Extramural

MeSH terms

Antihypertensive Agents / therapeutic use*
Asian*
Black or African American*
Female
Health Knowledge, Attitudes, Practice
Health Status Disparities*
Healthcare Disparities / ethnology
Hispanic or Latino*
Humans
Hypertension / drug therapy
Hypertension / epidemiology*
Hypertension / ethnology
Male
Middle Aged
Prevalence
United States / epidemiology
White People*

Substances

Antihypertensive Agents

Grants and funding